CVS, Barclays and Medicare
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage. Despite macroeconomic pressures impacting the retail pharmacy sector,
Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...
The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.
Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...
CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people ...
Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback